URGN peer analysis
UroGen Pharma (URGN) against its competitors: price, today's move, 1-year return and market value side by side.
URGN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CGON CG Oncology | $61.97 | -4.19% | 45.91% | – |
| RLMD Relmada Therapeutics | $3.58 | 4.07% | 54.31% | $381.88M |
| URGN UroGen Pharma | $34.35 | 4.98% | 73.05% | $1.60B |
- URGN's peers: CGON (CG Oncology), RLMD (Relmada Therapeutics).
Updated 2026-11-02 23:14 UTC